Occurrence and Disease Course of RSV Illness in Adults
Released On
August 30, 2024
Expires On
August 30, 2025
Media Type
Internet
Completion Time
60 minutes
Specialty
Critical Care, Education, Emergency Medicine, Geriatric Medicine, Home Care, Hospitalist, Infectious Disease, Primary Care, Pulmonology
Topics
Adult Vaccination, Respiratory
This activity is provided by the American Thoracic Society, American Academy of Physician Associates, and The France Foundation.
This educational activity is supported by an independent medical educational grant from GSK.
Credit Available
- Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™
- ABIM MOC - 1.0 Medical Knowledge MOC points
- AAFP - 1.0 Enduring Materials Prescribed credits
- Nurses - 1.0 contact hours of nursing continuing professional development credit
- Pharmacists - 1.0 contact hours (0.10 CEUs) of continuing pharmacy education credit
All other healthcare professionals completing this course will be issued a statement of participation
Target Audience
This educational activity is intended for US-based healthcare professionals who care for older adults, including pulmonologists, geriatricians, and additional primary care providers (family physicians, internists, physician associates, nurse practitioners and other nursing professionals, and pharmacists).
Program Overview
Respiratory syncytial virus (RSV) is a highly contagious seasonal lower respiratory tract infection (LRTI) characterized by cough, runny nose, sneezing, wheezing, sore throat, fatigue, decreased appetite, and fever, affecting children and adults. RSV can be particularly dangerous for older adults, who experience more severe disease as a consequence of increased vulnerability to infection. This multi-modal and interactive education will review the mechanism of RSV illness and summarize the disease burden of RSV in adults, with a focus on hospitalizations, comorbidities, and related health disparities.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Recognize the prevalence of RSV illness in older adults
- Describe the mechanism and signs/symptoms of RSV illness in older adults
Faculty
Sarah McQueen, PA-C
Family Medicine Physician Associate
Dayspring Health
Williamsburg, KY
Justin R. Ortiz, MD, MS
Pulmonary Critical Care, Infectious Diseases
Professor of Medicine, University of Maryland School of Medicine
Baltimore, MD
Accreditation Statement- American Thoracic Society
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Thoracic Society, American Academy of Physician Associates, and The France Foundation. The American Thoracic Society is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
The American Thoracic Society designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABP MOC credit.
Accreditation Statement- The France Foundation
In support of improving patient care, this activity has been planned and implemented by The France Foundation, the American Thoracic Society, and the American Academy of PAs. The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Family Physicians
The AAFP has reviewed “Conserving the Health of Older Adults Through RSV Education” and deemed it acceptable for AAFP credit. Term of approval is from 07/31/2024 to 07/30/2025. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This session, “Occurrence and Disease Course of RSV Illness in Adults,” is approved for 1.0 Enduring Materials AAFP Prescribed credits.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
Nurses - The France Foundation
The France Foundation designates this activity for 1.0 contact hours.
Pharmacists - The France Foundation
This knowledge-based activity, UAN JA0007204-9999-24-062-H01-P, qualifies for 1.0 contact hours (0.10 CEUs) of continuing pharmacy education credit. Please submit all evaluations and credit requests no later than 30 days after you complete this activity to ensure your credit fulfillment, as CE credit cannot be awarded past 60 days from the activity date. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service ([email protected]).
All other healthcare professionals completing this course will be issued a statement of participation.
Disclosures of Conflicts of Interest
It is the policy of the ATS to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. As an accredited CME provider, the ATS requires that its planners, reviewers, and presenters comply with the ACCME Standards Integrity and Independence in Accredited Continuing Education. The ATS also requires specific disclosure of relationships with companies and organizations associated with tobacco or cannabis and prohibits or limits participation of faculty in official ATS activities, including CME, if any tobacco industry relationship or some types of cannabis industry relationship is present. The most recent policies regarding potential conflicts of interest as well as the mechanisms to mitigate or resolve such conflicts can be found here: COI Policy for Official ATS Activities (thoracic.org)
Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.
Instructions for Participation and Credit
There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, completing the pretest, completing the activity, and completing the posttest and evaluation form. A score of at least 75% on the posttest is required to successfully complete this activity. The participant may take the test until successfully passed.
Credit Fulfillment
- If you are requesting AMA credits, ANCC credits, AAFP credits, or a certificate of participation, your certificate will be available for download.
- If you are a pharmacist requesting ACPE credits, your credit request will be uploaded to CPE Monitor within 60 days.
- If you are requesting MOC credit, your MOC points will be submitted electronically to the ACCME, which will register data and notify certifying boards. Points will be awarded to your board on a monthly basis.
Course Viewing Requirements
This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox, and Safari browsers.
Additionally, this site and its activities are best viewed using the latest operating system for your device.
Disclosure of Unlabeled Use
ATS, AAPA, and TFF require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. ATS, AAPA, and TFF do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
Disclaimer
ATS, AAPA, and TFF present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. ATS, AAPA, and TFF and the commercial supporter(s) assume no liability for the information herein.
Contact Information
If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or [email protected].